Clinical key message:
Despite the little information about the facial papules due to LPP, we
have many cases with facial skin roughness in which histological study
have showed LPP. Additionally, in those patients treating for FFA or
scalp LPP there were no improvement in facial papules.
Keywords: lichen planopilaris, frontal fibrosing alopecia,
facial papules, isotertinoin,
Introduction
Lichen planopilaris (LPP) is the most common scaring alopecia
characterized by lymphocytic infiltration around hair follicles.
Although it is considered an autoimmune disease, its exact mechanism of
pathogenesis is still unknown (1). Frontal fibrosing alopecia (FFA) is a
distinctive form of primary lymphocytic cicatricial alopecia,
considering as a variant of LPP (2). FFA has markedly increased over the
last years and considered “a growing epidemic” disease (3, 4). It
mostly affects postmenopausal women, but it is also described in
premenopausal women and men (3). Association with autoimmune diseases
has also been reported (e.g. hypothyroidism) (5,6). Eventually, the
number of cases with FFA has increased in recent years as a result of
rising incidence (7). It has been considered as a variant of LPP that
involves scalp hairs in frontotemporal hairlines, eyebrows and
eyelashes. Involvement of facial vellus hairs presented as skin-colored
follicular papules due to lichenoid perifollicular inflammation was
first described by Donati et al. in 2011 (8). Beside it may be
accompanied with body vellus hair involvement suggests that FFA has more
pathological expansion (9-11). Facial vellus hair involvement is
reported as a clinical feature of FFA in the majority of studies,
although there are some rare reports of facial LPP in the absence of
scalp disease (12).
Herein we present 14 patients with facial papules who have scalp
involvement (FFA or LPP) and 5 patients with isolated facial LPP in the
absence of other sites of disease activity and evaluate response to
treatment with isotretinoine.
Cases’ presentation
This case series study was performed on 19 patients with facial papule
referred to Alzahra hospital and clinics affiliated with Isfahan
University of Medical Sciences in Isfahan-Iran during 2018-2019.
Patients who met the inclusion criteria were those with clinical feature
of facial papules whose diagnosis was proved histopathologically. To
quantify pre-treatment and post-treatment response to isotretinoin, we
use Global Improvement Scale Assessments (GISA)
Nineteen patients were diagnosed with facial LPP enrolled to the study.
Except for 2 males all patients in this series were females (41.17%
postmenopausal and 58.82% premenopausal). The average patients age was
from 32 to 68 years with mean age ± SD of 49.36 ± 11.61. FFA was found
in 9 (52.9%) patients who were all females, whereas classic form of LPP
was evident in 5 (29.4%) patients (2 males and 3 females). Five
(29.4%) patients who were all females presented only with facial LPP
without other sites involvement.
Concerning the presenting signs and symptoms, 9 (47.36%) patients had
been referred with chief complaints facial skin roughness. Interestingly
some of these patients were misdiagnosed and undergo laser resurfacing
(2 cases) and needle radiofrequency (1 case) for their lesions.
Following these procedures exacerbation of facial lesions, suggesting
Koebner’s phenomenon were observed. In 10 out of 19 cases, facial papule
was recognized following scalp involvement.
Two male and three female patients with LPP of scalp were undergone
treatment with systemic drugs (cyclosporine, hydroxychloroquine and or
MTX, prednisolone, and phototherapy) for LPP of scalp, but in none of
them facial papules respond to these treatments.
We observed different clinical patterns of facial papules according to
age and sex of the patients. All patients who were older than 50 years
(postmenopausal women) have subtle clinical expression and had
previously been given a diagnosis of LPP or FFA. On the other hand
facial lesions were better observed in younger patient and many of them
present with such lesions. Two male patients presented with severe
papular eruption over the face. In both of them, physical examination
revealed LPP of the scalp.
The shape of lesions and pattern of their distribution varied between
males and females and in female patients; also There was difference
between patients under 50 years of age and those over 50 years of age
(Fig.1 and Table.1).
In 11 of 19 cases (64.7%) eyebrows eyebrows were affected – partially
in 9 patients (47.36%) and totally in 2 patients (10.52%) – whereas
eyelash loss were present in 2 patients (10.52%).
The skin biopsy of facial papules showed lymphocytic infiltration around
the vellus hairs accompanied by vacuolar degeneration of basal
epithelium of these hairs and replacement of vellus hairs by fine
fibrous tracts.
The patients were provided with an adequate explanation about the
project and informed consent was obtained. All patients referred to the
laboratory for initial blood tests including CBC, BUN, Cr, LFT and
beta-HCG for female patients, ., patients received 20 mg of isotretinoin
orally daily for 6 months. During treatment course, follow-up
appointment was arranged after 1, 2, 4 and 6 months of treatment.
Comparison of the change in lesions and the 4-point grading scale score
(table….) from base line was performed, based on photography.
After 6 months of treatment, before and after photographs were scored by
a blind dermatologist. Response to treatment was dramatic in 2 males and
significantly varied with female patients and in a way; the lesions were
significantly reduced after 6 month of treatment. 10 patients (58.8%)
were satisfied with the treatment and 3 cases (17%) had satisfactory
results. The papular lesions were clearly reduced, and the skin was
smoother especially in male patients (Fig.2), but this treatment did not
affect the FFA and LPP of scalp.
Improvement with oral isotretinoin was apparent in all patients within 6
months. Many papular lesions disappeared rapidly and remained smooth
skin. At the last visit, 63.15% of the patients stated that they were
satisfied with the results of the of the treatment. Interestingly, scalp
disease not affected by such treatment.
The scoring system was used to evaluate the treatment results by a
dermatologist was as: 0 = no response, 1 = mild to moderate response, 2
= good response and 4 = a very good response.
The response to treatment in patients was evaluated by a blinded
dermatologist and according to her opinion, 42.1% of patients had a
good response and 26.3% had a very good response (Table.2).